Liver surgery for pancreatic cancer that has spread to the liver
Part of Cancer, Digestive system clinical trials.
This study tests whether surgery to remove liver tumors from pancreatic cancer can improve outcomes. It is for patients whose cancer has spread only to the liver, and the tumor can be safely removed or destroyed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have pancreatic cancer that has spread only to your liver.
- You have up to 4 liver tumors that can be removed by surgery or destroyed with heat or other techniques (tumors smaller than 5 cm for surgery, or smaller than 2 cm for ablation).
- You are in good physical condition (able to do light work or fully active).
- Your cancer has not grown or spread during or after chemotherapy (if you have received it).
- You do not have other serious health problems that would make treatment unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares surgery to remove the primary tumor and up to 3 liver spots against standard palliative care for people with pancreatic cancer that has spread only to the liver (up to 3 spots). It is for those whose cancer has not grown after initial chemotherapy and who are healthy enough for surgery.
This trial is for people with pancreatic cancer that has spread to the liver (3 spots or fewer). It tests whether removing both the original tumor and the liver spots after a specific chemotherapy (FOLFIRINOX) can be helpful. You may be eligible if the chemo shrinks the tumors enough and you are healthy enough for surgery.
This trial tests whether removing or ablating limited liver or lung tumors from pancreatic cancer that has not spread elsewhere, along with a specific chemotherapy (NALIRIFOX), can help patients. It is for people who have not had any previous cancer treatment.
This trial tests a treatment for pancreatic cancer that has spread to the liver (with no more than a few liver tumors). Patients will receive chemotherapy plus surgery and a heat-based procedure (thermal ablation) to destroy the liver tumors. The goal is to see if combining these treatments helps control the cancer better than chemotherapy alone.
This study tests advanced treatments for cancer that has spread to the liver, either from colon cancer or pancreatic cancer. It may help by targeting liver tumors using treatment plans and, for some participants, liver tissue samples.
This study tests a new treatment combining tumor destruction with heat/cold (ablation) and an immunotherapy drug (PD-1) for people whose pancreatic cancer has spread to the liver. The goal is to help the immune system fight the cancer better.
Hear when a new Disseminated Pancreatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.